472 related articles for article (PubMed ID: 14562884)
1. Development of a virosome vaccine for Newcastle disease virus.
Kapczynski DR; Tumpey TM
Avian Dis; 2003; 47(3):578-87. PubMed ID: 14562884
[TBL] [Abstract][Full Text] [Related]
2. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
Nagy E; Krell PJ; Dulac GC; Derbyshire JB
Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
[TBL] [Abstract][Full Text] [Related]
4. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
5. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
[TBL] [Abstract][Full Text] [Related]
6. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
7. Protection from clinical disease against three highly virulent strains of Newcastle disease virus after in ovo application of an antibody-antigen complex vaccine in maternal antibody-positive chickens.
Kapczynski DR; Martin A; Haddad EE; King DJ
Avian Dis; 2012 Sep; 56(3):555-60. PubMed ID: 23050473
[TBL] [Abstract][Full Text] [Related]
8. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
Cornax I; Miller PJ; Afonso CL
Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
[TBL] [Abstract][Full Text] [Related]
9. Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers.
Palya V; Tatár-Kis T; Mató T; Felföldi B; Kovács E; Gardin Y
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):105-15. PubMed ID: 24368086
[TBL] [Abstract][Full Text] [Related]
10. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
11. Determination of minimum hemagglutinin units in an inactivated Newcastle disease virus vaccine for clinical protection of chickens from exotic Newcastle disease virus challenge.
Liljebjelke KA; King DJ; Kapczynski DR
Avian Dis; 2008 Jun; 52(2):260-8. PubMed ID: 18646455
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV.
Iritani Y; Aoyama S; Takigami S; Hayashi Y; Ogawa R; Yanagida N; Saeki S; Kamogawa K
Avian Dis; 1991; 35(4):659-61. PubMed ID: 1664717
[TBL] [Abstract][Full Text] [Related]
13. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
[TBL] [Abstract][Full Text] [Related]
14. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
15. Development of a recombinant NP protein based indirect ELISA for the detection of antibodies against Newcastle disease virus and differentiation of infected or recombinant vaccine immunized chickens.
Domańska-Blicharz K; Tyborowska J; Sajewicz-Krukowska J; Olszewska-Tomczyk M; Rąbalski Ł; Kucharczyk K; Szewczyk B; Śmietanka K
Pol J Vet Sci; 2019 Sep; 22(3):531-540. PubMed ID: 31560459
[TBL] [Abstract][Full Text] [Related]
16. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
[TBL] [Abstract][Full Text] [Related]
18. Antigenic variation of LaSota and genotype VII Newcastle disease virus (NDV) and their efficacy against challenge with velogenic NDV.
Yang HM; Zhao J; Xue J; Yang YL; Zhang GZ
Vaccine; 2017 Jan; 35(1):27-32. PubMed ID: 27889255
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and protective efficacy of virosome based vaccines against Newcastle disease.
Singh R; Verma PC; Singh S
Trop Anim Health Prod; 2010 Mar; 42(3):465-71. PubMed ID: 19728133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
